Published: Guidance, quality standards and advice
Showing 41 to 43 of 43
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation | TA311 | ||
| Bortezomib and thalidomide for the first‑line treatment of multiple myeloma | TA228 | ||
| Bortezomib monotherapy for relapsed multiple myeloma | TA129 |